Abstract

The success of dental implants has been attributed to various factors, including the patient’s general health, oral hygiene practices, and medication usage. However, the interaction between pharmacological agents such as Selective Serotonin Reuptake Inhibitors (SSRIs) and dental implant failure remains an underexplored area in dental research. SSRIs are commonly prescribed for the treatment of depression, anxiety, and other mood disorders. This study aims to investigate the relationship between SSRI usage and dental implant failure, with a particular focus on clinical histories. Through a comprehensive review of patient records, clinical reports, and current literature, we assess whether SSRIs contribute to higher failure rates of dental implants and the potential underlying mechanisms. Our findings suggest that SSRI use may be associated with an increased risk of dental implant failure, warranting further investigation and potential reevaluation of clinical practices regarding SSRI prescription in patients undergoing dental implant procedures.